Methyl 2-(4-tosylpiperazin-1-yl)acetate

Catalog No. :
ACCFAI708
CAS No. :
681226-60-8
Molecular Formula :
C14H20N2O4S
Molecular Weight :
312.39

IUPAC Name:methyl 2-(4-tosylpiperazin-1-yl)acetate

Methyl 2-(4-tosylpiperazin-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$83.00Login to see priceInquiryInquiry
250mg98%$111.00Login to see priceInquiryInquiry
1g98%$278.00Login to see priceInquiryInquiry
5g98%$855.00Login to see priceInquiryInquiry
10g98%$1270.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(4-tosylpiperazin-1-yl)acetate
IUPAC Namemethyl 2-(4-tosylpiperazin-1-yl)acetate
MDL No.MFCD06056378
Molecular FormulaC14H20N2O4S
Molecular Weight312.39
SMILESO=C(OC)CN1CCN(S(=O)(C2=CC=C(C)C=C2)=O)CC1
InChI KeyMBHMLZWODJGKCG-UHFFFAOYSA-N
SynonymMethyl 2-[4-(4-methylbenzenesulfonyl)piperazin-1-yl]acetate;1-Piperazineacetic acid, 4-[(4-methylphenyl)sulfonyl]-, methyl ester
CAS No.681226-60-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCFAI708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBYOM762 route compound structure diagram
    ACBYOM762856843-84-0 In Stock
  4. Then
  5. ACCFAI708 route product structure diagram
    ACCFAI708681226-60-8
Inquiry

2. ACCFAI708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNIAL571 route compound structure diagram
    ACNIAL571179689-65-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFAI708 route product structure diagram
    ACCFAI708681226-60-8
Inquiry

Comments (0)